127 related articles for article (PubMed ID: 38513830)
21. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
22. Merkel cell carcinoma and melanoma: etiological similarities and differences.
Miller RW; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):153-8. PubMed ID: 10067813
[TBL] [Abstract][Full Text] [Related]
23. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract][Full Text] [Related]
24. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
[TBL] [Abstract][Full Text] [Related]
25. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
26. Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact.
Barclay ME; Abel GA; Greenberg DC; Rous B; Lyratzopoulos G
Br J Cancer; 2021 Mar; 124(7):1320-1329. PubMed ID: 33564123
[TBL] [Abstract][Full Text] [Related]
27. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
28. Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).
Najita JS; Swetter SM; Geller AC; Gershenwald JE; Zelen M; Lee SJ
J Invest Dermatol; 2016 Sep; 136(9):1894-1897. PubMed ID: 27251792
[No Abstract] [Full Text] [Related]
29. Melanoma incidence and survival in patients with myelodysplastic syndrome: A matched cohort population-based study.
Barriera-Silvestrini P; Xiong DD; Lewis S; Knackstedt T
J Am Acad Dermatol; 2021 Feb; 84(2):502-505. PubMed ID: 32376434
[No Abstract] [Full Text] [Related]
30. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
31. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
32. Second primary malignancies associated with renal cell carcinoma: influence of histologic type.
Rabbani F; Reuter VE; Katz J; Russo P
Urology; 2000 Sep; 56(3):399-403. PubMed ID: 10962302
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
34. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
35. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
36. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
37. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
[TBL] [Abstract][Full Text] [Related]
38. Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries.
Bergmans R; Soliman AS; Ruterbusch J; Meza R; Hirko K; Graff J; Schwartz K
Am J Public Health; 2014 Jun; 104(6):e83-91. PubMed ID: 24825237
[TBL] [Abstract][Full Text] [Related]
39. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
40. [The risk of second primary neoplasm in prostatic cancer patients].
Osca García JM; Morera Martínez JF; Alfonso Gil R; Catalá Barceló T; Ruiz Cerdá JL; Martínez Jabaloyas JF; Jiménez Cruz JF
Actas Urol Esp; 1993 Oct; 17(9):574-8. PubMed ID: 8165938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
